AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact Did you know? Postpartum hemorrhage (PPH) is the leading cause of maternal death worldwide. AMPLI-PPHI will catalyze early adoption and scale-up of new and recently recommended drugs to prevent or treat PPH in high-burden countries as part of an integrated package of
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
Jhpiego promotes vaccination efforts across three continents. JHU Hosts a Real-Time Map of COVID-19’s Global Spread We are a proven leader in training vaccinators, community health workers and others supporting vaccination efforts and ensuring quality at vaccination sites to promote vaccine confidence. That’s why our teams are at the forefront of vaccine planning, introduction and scale-up
